Tell Me Y: Anticipation of Sex Discrepancies in Cell-free DNA Testing Due to Maternal Genetic Abnormalities: a Case Report

Overview

Journal Front Genet

Date 2025 Feb 4

PMID 39902298

Authors

Nuria Balaguer

Emilia Mateu-Brull

Jose Antonio Martinez-Conejero

Ana Cervero

Roser Navarro

Jorge Jimenez-Almazan

Miguel Milan

Affiliations

Soon will be listed here.

Abstract

Sex discordance between cell-free DNA (cfDNA) testing and ultrasound examination is rare but can cause significant patient discomfort and uncertainty. Here, we present two clinical cases where a closer examination of raw sequencing data allowed us to anticipate possible discrepancies caused by the insertion of Y-chromosome regions into the maternal genome. We used Illumina's VeriSeq NIPT Solution v2 and a proprietary bioinformatics pipeline to analyze cfDNA in the maternal bloodstream. Paired-end sequencing data were aligned to the reference genome (). Non-duplicated aligned reads were aggregated into 100-kb bins, adjusted for CG bias, and further aggregated into 5-Mb windows. Z-scores were calculated for autosomes, sex chromosomes, and 5-Mb bins. The two clinical cases were classified as low-risk male fetuses according to the primary statistics (case A: NCV = 0.3; NCV = 40.6; native fetal fraction (FF) = 5.1%, and case B: NCV = -0.3, NCV = 40.7, FF = 10.8%); however, the Y-chromosome-based FF (FF) was significantly lower than the default FF estimate (FF ≅ 2% in both cases). Plots of X and Y chromosome Z-scores for each 5-Mb bin, according to genomic position, identified bins with Z-scores significantly higher than those expected for any pregnancy with a male fetus. The genomic coordinates of these bins overlapped with the amelogenin () and protein kinase Y-linked () genes, respectively. Amplification of these regions in the DNA isolated from the white blood cells fraction confirmed the presence of Y-chromosome insertions in the maternal genome. This study highlights a new source of discrepancy in cfDNA testing due to maternal genomic variations. These findings suggest the need for improvements to current bioinformatics pipelines to identify and exclude possible maternal perturbations from the classification algorithms used for aneuploidy and sex calls.

References

Mannucci A, Sullivan K, Ivanov P, Gill P . Forensic application of a rapid and quantitative DNA sex test by amplification of the X-Y homologous gene amelogenin. Int J Legal Med. 1994; 106(4):190-3. DOI: 10.1007/BF01371335. View

Xi R, Lee S, Xia Y, Kim T, Park P . Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants. Nucleic Acids Res. 2016; 44(13):6274-86. PMC: 5772337. DOI: 10.1093/nar/gkw491. View

Raman L, Dheedene A, De Smet M, Van Dorpe J, Menten B . WisecondorX: improved copy number detection for routine shallow whole-genome sequencing. Nucleic Acids Res. 2018; 47(4):1605-1614. PMC: 6393301. DOI: 10.1093/nar/gky1263. View

Rose N, Barrie E, Malinowski J, Jenkins G, McClain M, LaGrave D . Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies. Genet Med. 2022; 24(9):1992. DOI: 10.1016/j.gim.2022.07.002. View

Bayindir B, Dehaspe L, Brison N, Brady P, Ardui S, Kammoun M . Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur J Hum Genet. 2015; 23(10):1286-93. PMC: 4592078. DOI: 10.1038/ejhg.2014.282. View

Sullivan K, Mannucci A, Kimpton C, Gill P . A rapid and quantitative DNA sex test: fluorescence-based PCR analysis of X-Y homologous gene amelogenin. Biotechniques. 1993; 15(4):636-8, 640-1. View

Smet M, Scott F, McLennan A . Discordant fetal sex on NIPT and ultrasound. Prenat Diagn. 2020; 40(11):1353-1365. DOI: 10.1002/pd.5676. View

Dungan J, Klugman S, Darilek S, Malinowski J, Akkari Y, Monaghan K . Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2022; 25(2):100336. DOI: 10.1016/j.gim.2022.11.004. View

Tozzo P, Giuliodori A, Corato S, Ponzano E, Rodriguez D, Caenazzo L . Deletion of amelogenin Y-locus in forensics: literature revision and description of a novel method for sex confirmation. J Forensic Leg Med. 2013; 20(5):387-91. DOI: 10.1016/j.jflm.2013.03.012. View

10.

Dhamankar R, DiNonno W, Martin K, Demko Z, Gomez-Lobo V . Fetal Sex Results of Noninvasive Prenatal Testing and Differences With Ultrasonography. Obstet Gynecol. 2020; 135(5):1198-1206. PMC: 7170435. DOI: 10.1097/AOG.0000000000003791. View

11.

Wilson K, Czerwinski J, Hoskovec J, Noblin S, Sullivan C, Harbison A . NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy. J Genet Couns. 2012; 22(1):4-15. DOI: 10.1007/s10897-012-9545-3. View

12.

Chen W, Wu W, Cheng J, Zhang Y, Chen Y, Sun H . Detection of the deletion on Yp11.2 in a Chinese population. Forensic Sci Int Genet. 2013; 8(1):73-9. DOI: 10.1016/j.fsigen.2013.07.003. View

13.

Kotsopoulou I, Tsoplou P, Mavrommatis K, Kroupis C . Non-invasive prenatal testing (NIPT): limitations on the way to become diagnosis. Diagnosis (Berl). 2018; 2(3):141-158. DOI: 10.1515/dx-2015-0002. View

14.

Boeva V, Zinovyev A, Bleakley K, Vert J, Janoueix-Lerosey I, Delattre O . Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization. Bioinformatics. 2010; 27(2):268-9. PMC: 3018818. DOI: 10.1093/bioinformatics/btq635. View

15.

Scheinin I, Sie D, Bengtsson H, van de Wiel M, Olshen A, van Thuijl H . DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 2014; 24(12):2022-32. PMC: 4248318. DOI: 10.1101/gr.175141.114. View

16.

Klambauer G, Schwarzbauer K, Mayr A, Clevert D, Mitterecker A, Bodenhofer U . cn.MOPS: mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate. Nucleic Acids Res. 2012; 40(9):e69. PMC: 3351174. DOI: 10.1093/nar/gks003. View

17.

Lo Y, Tein M, Lau T, Haines C, Leung T, Poon P . Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998; 62(4):768-75. PMC: 1377040. DOI: 10.1086/301800. View

18.

Talevich E, Shain A, Botton T, Bastian B . CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing. PLoS Comput Biol. 2016; 12(4):e1004873. PMC: 4839673. DOI: 10.1371/journal.pcbi.1004873. View

19.

Kumagai R, Sasaki Y, Tokuta T, Biwasaka H, Aoki Y . DNA analysis of family members with deletion in Yp11.2 region containing amelogenin locus. Leg Med (Tokyo). 2007; 10(1):39-42. DOI: 10.1016/j.legalmed.2007.05.009. View

20.

Kim S, Hannum G, Geis J, Tynan J, Hogg G, Zhao C . Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts. Prenat Diagn. 2015; 35(8):810-5. DOI: 10.1002/pd.4615. View